In the process of novel coronavirus pneumonia, Chinese medicine played an important role. According to the data, except for Hubei, 96.37% of the cases were treated by TCM, and 91.05% of the cases were treated by TCM in Hubei. It is evident that novel coronavirus pneumonia is "effective" in the prevention and control of the new crown pneumonia.

Since the outbreak of the epidemic, the government has repeatedly emphasized the combination of traditional Chinese and Western medicine, and has actively promoted the timely and comprehensive intervention of traditional Chinese medicine in the whole process of diagnosis and treatment. The novel coronavirus pneumonia treatment and practice showed that early intervention and integrated Chinese and Western medicine treatment is an important way to improve the cure rate and reduce the mortality rate of Yu Yanhong, said the central steering group member, the health and health committee member and the party secretary and deputy director of the Chinese medicine bureau. Zhang Boli, academician of the Chinese Academy of engineering and President of Tianjin University of traditional Chinese medicine, also said in the CCTV special report on the war "epidemic", that "when patients suffer from poor breathing, unstable blood oxygen or organ damage, the dosage of traditional Chinese medicine will be increased, especially some traditional Chinese medicine injection plays a very important role in the treatment process."

Professor Yang Zifeng novel coronavirus pneumonia novel coronavirus pneumonia, Professor of medicine, and professor of medicine, Professor Yang Zifeng introduced the research situation of Chinese medicine for treating new crown pneumonia: at present, many medical and scientific research institutions in Guangdong separated virus from P3 laboratory, and launched a screening of 54 effective drugs. It was found that Lianhuaqingwen capsule, Liushen capsule pill, Jinzhen oral liquid, Reduning injection and other five Chinese patent medicines had inhibitory effect on neocoronavirus in vitro. The national version of novel coronavirus pneumonia diagnosis and treatment plan (Trial Implementation) has been released to the seventh edition, including the Chinese patent medicine such as "Huo Xiang Zheng Qi", "Jinhua Qinggan", "Lianhua Qingwen", "dispersing wind and detoxifying", and so on, and also have many Chinese Medicine injections recommended such as Xi Yan Ping, Xue Bi Jing, Redu Ning, Tanreqing, Xingnaojing.

Through open channels, we know that two traditional Chinese medicine products, Reduning injection and Jinzhen oral liquid, belong to Jiangsu Kangyuan pharmaceutical industry. Jiangsu Kangyuan Pharmaceutical Co., Ltd. is a large-scale traditional Chinese medicine enterprise integrating drug R & D, production and sales, and one of the top 100 pharmaceutical enterprises in China. During the anti epidemic period, Kangyuan Pharmaceutical Co., Ltd. produced and donated 44.53 million yuan of Jinzhen oral liquid, Reduning injection and other drugs and love money needed for the epidemic, and accepted the entrustment from the epidemic prevention and control headquarters of Wuchang District, Wuhan City, to process and produce the new crown virus pneumonia prevention and control treatment traditional Chinese medicine agreement developed by Tong Xiaolin, Chinese Academy of traditional medicine.

The novel coronavirus pneumonia has been effective in treating febrile diseases and emergencies since its development. The new crown pneumonia epidemic has highlighted the therapeutic effect of Chinese medicine, which helps to enhance people's cognition and acceptance of Chinese medicine. China's novel coronavirus pneumonia will also continue to play a key role in the prevention and treatment of epidemic diseases. The first batch of Chinese patent medicines will also be used as aid for Italy's medical supplies.

Source：https://www.thepaper.cn/newsDetail_forward_6800049

Time：2020.04.02